Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Oncol., 16 October 2025

Sec. Genitourinary Oncology

Volume 15 - 2025 | https://doi.org/10.3389/fonc.2025.1559861

Case Report: Malignant peripheral nerve sheath tumor of the kidney with a novel granular cell morphology

  • 1Department of Pathology, General Hospital of Southern Theater Command, People’s Liberation Army of China, Guangzhou, China
  • 2Department of Urology, Nanfang Hospital, Southern Medical University, Guangzhou, China
  • 3Graduate School, Guangzhou University of Chinese Medicine, Guangzhou, China

Malignant peripheral nerve sheath tumors (MPNSTs) arising from the kidney are rare. The present report describes a renal MPNST of a 33-year-old man exhibiting novel morphological features. Histologically, the tumor was comprised of spindle Schwann cells and granular-like tumor cells. The latter are characterized by large, round-to-polygonal cells with abundant, finely granular eosinophilic cytoplasm, which form variable nodules or are diffusely distributed among the spindle tumor elements. Immunohistochemistry revealed both tumor components expressed CD56, Leu-7, PGP9.5, and Nestin, indicating a neural crest origin. A complete loss of H3K27me3 expression confirmed the diagnosis of MPNST. The patient had no history of neurofibromatosis type 1. The granular cell changes in renal MPNST expand the known morphological spectrum of MPNSTs.

Introduction

Malignant peripheral nerve sheath tumors (MPNSTs) are spindle cell neoplasms that typically arise from peripheral nerves, showing variable differentiation toward nerve sheath cellular components, such as Schwann cells, fibroblasts or perineurial cells. They can occur sporadically or in patients with neurofibromatosis type 1. MPNSTs occur most frequently in the extremities, particularly proximally, followed by the trunk, head and neck. Previous reported have documented lesions in parenchymal organs such as the cervix, skull, heart, lung, adrenal gland and retroperitoneum (16). However, MPNSTs originating from the kidney are particularly rare (79). Heterologous differentiation, including skeletal muscle, bone, cartilage, blood vessels and glandular differentiation, is observed in approximately 15% of MPNST tumors. To date, granular cell changes have not been reported. This study reports a renal MPNST with granular cell differentiation and review the current literature, hoping to further expand knowledge of MPNSTs.

Case presentation

A 33-year-old overweight male patient (BMI, 25.9) presented with dull, constant left lumbar pain, accompanied by nausea, vomiting, and subsequent hematuria for 1 week. He had no family history of cancer or neurofibromatosis type 1. He did not smoke, drink, have irregular sleep habits, or frequent exposure to high temperatures and chemicals at work. Biochemical examination showed elevated low-density lipoprotein (LDL; 4.2 mmol/l). A large cystic-solid mass was found in the left kidney during a routine ultrasound examination. CT and MRI showed a large, encapsulated cystic-solid mass involving the left kidney, with gradual enhancement on post-contrast images, raising the possibility of renal cell carcinoma in differential diagnosis. The tumor measured ~13.4 × 9.8 × 7.8 cm, with relatively clear boundaries (Figures 1A, B). A left radical nephrectomy and lymph node dissection were performed.

Figure 1
MRI images A (coronal) and B (axial) show a renal mass indicated by red stars. Image C displays the gross specimen: black arrows point to renal tissue, while the tumor is marked by asterisk.

Figure 1. MRI showing a large tumor arising from the hilum of the left kidney. (A) Sagittal and (B) transverse view. (red arrows = tumor). Gross findings, the mass was located at the renal hilum and clearly demarcated from the surrounding renal tissue (C). (black arrows = renal tissue, asterisk = tumor).

Grossly, A protruding, round mass was found in the kidney, measuring approximately 13.0×10.0×8.0 cm at the renal hilum, sharply demarcated from the surrounding renal parenchyma, with a distinct fibrous pseudo-capsule. The cut surface of the mass exhibited a grayish-red color, a soft consistency, and a fish-flesh-like appearance. Additionally, areas of gelatinous, solid and hemorrhage areas were observed (Figure 1C). Microscopically, the tumor was composed of spindle tumor cells reminiscent of Schwann cells and large granular-like cells with eosinophilic cytoplasm. The granular-like cells were either distributed modularly or diffusely interspersed with the spindle cells (Figures 2A, B). The spindle tumor cells had minimal amphophilic cytoplasm and showed elongated, buckled or wavy nuclei with hyperchromatic or vesicular nuclei (Figure 2C). The granular-like cells were round-to-polygonal, with distinct cell borders and abundant, finely granular eosinophilic cytoplasm (Figure 2D). Nuclei varied in morphology, ranging from uniformly small and mildly hyperchromatic to larger and vesicular with distinct nucleoli. Mitoses, including atypical mitoses, were more easily found in granular-like cells compared with the spindle elements (Figure 2E). The normal renal tubules were frequently entrapped at the periphery (Figure 2F). The gelatinous areas are attributed to the presence of myxoid stroma, necrosis and hemorrhagic components within the tumor. Immunohistochemistry showed that both the spindle and granular-like tumor cells were positive for Nestin, Leu-7, PGP9.5, CD56 and BCL2 (Figures 3A–E). Tumor cells were negative for S-100 (Figure 3F), SOX10, Desmin, MyoD1, GFAP, keratin, EMA, WT1, CD34, STAT6, HMB45, Melan-A, P16, P53 and MDM2. Both tumor components showed complete loss of H3K27me3 staining, with retained expression in endothelial cells (Figure 3G). The entrapped renal tubules show positive staining for keratin7 and PAX8 (Figures 3H, I). The renal cell carcinoma was excluded due to spindle-shaped tumor cells and immunohistochemistry showed negative expression of keratin and EMA. A diagnosis of high-grade MPNST was confirmed, which was further classified as T2N0MX, stage IIIA.

Figure 2
Malignant peripheral nerve sheath tumor with granular cell-like changes. (A) Granular tumor cells form nodules or diffuse sheets among spindle cells. (B) Alternating dense and loose areas create a marbling pattern. (C) Spindle cells show elongated, wavy, hyperchromatic nuclei. (D) Granular cells are large with eosinophilic granular cytoplasm. (E) Mitoses (black arrows) more frequent in granular cells. (F) Entrapped normal renal tubules at periphery.

Figure 2. Malignant peripheral nerve sheath tumor with granular cell-like changes. The granular-like tumor cells either formed nodules of variable size or were diffusely distributed among the spindle cells (A) Magnification, x100. The tumor cells are arranged in a pattern of alternating density, presenting a marbling appearance (B) magnification, x200. (C) Spindle cells had elongated, buckled or wavy nuclei with hyperchromatic nuclei. (D) Granular cells were large, with granular and eosinophilic cytoplasm. (E) Mitoses were more easily found in granular-like tumor cells compared with the spindle elements and (F) normal renal tubules were frequently entrapped at the periphery. Magnification, x400. Black arrows indicate mitoses.

Figure 3
Immunohistochemistry panels A–E show granular and spindle tumor cells with brown positivity for Nestin, Leu-7, PGP9.5, CD56 and BCL2. F: S-100 is negative. G: H3K27me3 is completely lost in tumor cells; endothelial nuclei serve as internal positive controls. H: entrapped renal tubules stain positive for CK7. I: trapped tubules are also PAX8-positive. All images ×400; green arrows mark granular-like cells, yellow arrows mark spindle cells.

Figure 3. Granular-like tumor cells and spindle cells showed immunoreactivity for (A) Nestin, (B) Leu-7, (C) PGP9.5, (D) CD56 and (E) BCL2. (F) Negative staining for S‑100 protein. (G) A complete expression loss for H3K27me3 was shown in tumor cells, wheres the endothelial cells were nucleated positive. Entrapped renal tubules were positive for (H) keratin7 and (I) PAX8. Magnification, x400. Green arrows indicate Granular-like tumor cells and yellow arrows indicate spindle cells.

Discussion

MPNSTs are aggressive soft-tissue sarcomas that are typically associated with NF1, while approximately 40% of MPNSTs arise sporadically after radiation exposure. Renal MPNSTs are particularly rare that only 11 cases were reported from 2001–2023 in PubMed (717). The present study reported a patient who had a large mass in the renal hilus. Microscopically, the perivascular accentuation of tumor cells, hemangiopericytoma-like pattern, bright and dark appearance, cells with both a blunt and pointed end support the diagnosis of MPNST. In certain areas of the tumor, large epithelial-to-polygonal tumor cells with intensely granular, eosinophilic cytoplasm were present. These cells developed light-stained nodules of varying sizes or were interspersed with spindle Schwann cells. Immunoreactivity for CD56, Leu-7, PGP9.5 and Nestin was observed in both tumor components, which suggested a neural crest origin. A complete loss of H3K27me3 confirmed the diagnosis of MPNST (18, 19). Other spindle cell sarcomas that often arise from the kidney, such as synovial sarcoma and nephroblastoma, should be differentially diagnosed from MPNSTs. Synovial sarcoma typically shows focal keratin or EMA expression with possible H3K27me3 loss. MPNSTs also lack the specific t(X;18) translocation that is specific to synovial sarcoma (20). The entrapped renal tubules can be misdiagnosed as the epithelial component of classical nephroblastoma. Nephroblastomas characteristically contain undifferentiated blastemal cells and typically show WT1 immunoreactivity which is absent in MPNSTs (21). In addition, the plump, polygonal tumor cells with intensely eosinophilic cytoplasm and visible mitotic figures closely resemble a malignant granular cell tumor (GCT), which can be distinguished by strong, diffuse S-100 and SOX10 expression in GCT and its rarity in deep soft tissue sites.

GCT can be derived from Schwann cells. The inactivation of ATPase H+ Transporting Accessory Protein 1 (ATP6AP1) or ATP6AP2 leads to decreased vacuolar-type ATPase activity, which results in the aggregation of particles in the cytoplasm of Schwann cells (22). It has been previously reported that ATP6AP1 can affect lipid metabolism in humans (23). The LDL cholesterol levels of the patient were significantly elevated in this patient. Whether the granular cell changes are related to abnormal lipid metabolism requires further investigation from clinicians into whether additional treatment is required.

There are few reports on the molecular mechanism of sporadic MPNST (24). Reports show recurrent mutations in PRC2 core components EED and SUZ12 in MPNST, leading to global loss of H3K27me3. The loss of H3K27me3 expression is a useful diagnostic tool for high-grade MPNST. Hirbe et al. reported the oncogenic BRAF V600E mutation. In addition, TP53 mutations have also been identified in sporadic MPNSTs. Longo et al. showed that sporadic MPNSTs may also have the Cyclin Dependent Kinase Inhibitor 2A (CDKN2A)/p16 mutations, which are common in NF1-associated MPNSTs. BRAF V600E was detected using PCR and CDKN2A/p16 and TP53 mutation was detected using immunohistochemistry. In this study, the results showed that BRAF gene and CDKN2A/p16 were not mutated, however TP53 mutation was detected Other rare mutations, including DNA Methyltransferase 1, Nuclear Mitotic Apparatus Protein 1 and Neurotrophic Receptor Tyrosine Kinase 1 have been previously reported.

The present study novelly reported the granular cell changes of renal MPNST (25). Both the spindle and the granular-like tumor cells showed the same immunophenotype, but the latter had a higher mitotic rate. Divergent differentiation of MPNSTs into skeletal muscle/rhabdomyosarcoma, heterologous osteoid/osteosarcoma, chondroid/chondrosarcoma are common, but into angiosarcoma and epithelial elements are rare (2629). Granular cell changes associated with monomorphic spindled cells in humerus MPNSTs were previously reported by Ortiz (30), Focal expression of SOX10 and the complete loss of H3K27me3 confirmed the diagnosis. Our findings expand the known morphological spectrum of renal MPNSTs.

Conclusions

We reported a case of MPNST with a rare origin and unique morphological appearance Despite the interference of widely granular cell changes in malignant spindle sarcoma, typical morphological changes of MPNSTs and expression loss of H3K27me3 confirmed diagnosis. This special appearance further expands the morphological spectrum of MPNSTs and assists in making definite diagnosis.

Data availability statement

The original contributions presented in the study are included in the article/supplementary material. Further inquiries can be directed to the corresponding authors.

Ethics statement

The studies involving humans were approved by The Ethics Committee of General Hospital of Southern Theater Command, People’s Liberation Army of China. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article. Written informed consent was obtained from the participant/patient(s) for the publication of this case report.

Author contributions

DY: Conceptualization, Data curation, Investigation, Methodology, Writing – original draft, Writing – review & editing, Formal Analysis. GY: Data curation, Investigation, Methodology, Writing – original draft, Writing – review & editing, Formal Analysis. WC: Data curation, Formal Analysis, Visualization, Writing – original draft. XL: Data curation, Methodology, Resources, Supervision, Writing – original draft. WH: Data curation, Formal Analysis, Investigation, Writing – original draft. CL: Conceptualization, Project administration, Supervision, Validation, Writing – review & editing. WW: Conceptualization, Funding acquisition, Project administration, Resources, Supervision, Validation, Writing – original draft, Writing – review & editing.

Funding

The author(s) declare financial support was received for the research and/or publication of this article. This work was supported by Natural Science Foundation of Guangdong Province of China (2023A1515012384) and Science and Technology Planning Project of Guangzhou (No.2023A03J0169).

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declare that no Generative AI was used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Rodriguez AO, Truskinovsky AM, Kasrazadeh M, and Leiserowitz GS. Case report: Malignant peripheral nerve sheath tumor of the uterine cervix treated with radical vaginal trachelectomy. Gynecol Oncol. (2006) 100:201–4. doi: 10.1016/j.ygyno.2005.08.025

PubMed Abstract | Crossref Full Text | Google Scholar

2. Bruzzone E, Melloni I, Barra S, Fraternali Orcioni G, and Cocito L. A rare case of intracranial Malignant triton tumor arising in the middle cranial fossa: A case report and review of the literature. Folia Neuropathol. (2018) 56:229–34. doi: 10.5114/fn.2018.78704

PubMed Abstract | Crossref Full Text | Google Scholar

3. Li J, Chen Q, Yu S, and Yang S. Multiple primary cardiac Malignant peripheral nerve sheath tumors in the left atrium: case report. J Chest Surg. (2021) 54:422–4. doi: 10.5090/jcs.20.132

PubMed Abstract | Crossref Full Text | Google Scholar

4. La Mantia E, Franco R, Cantile M, Rocco R, De Chiara A, Martucci N, et al. Primary intrapulmonary Malignant peripheral nerve sheath tumor mimicking lung cancer. J Thorac Dis. (2013) 5:E155–7. doi: 10.3978/j.issn.2072-1439.2013.07.02

PubMed Abstract | Crossref Full Text | Google Scholar

5. de Chadarevian JP, MaePascasio J, Halligan GE, Katz DA, Locono JA, Kimmel S, et al. Malignant peripheral nerve sheath tumor arising from an adrenal ganglioneuroma in a 6-year-old boy. Pediatr Dev Pathol. (2004) 7:277–84. doi: 10.1007/s10024-004-8084-9

PubMed Abstract | Crossref Full Text | Google Scholar

6. Hou Z, Wang C, Li L, and Dong L. Retroperitoneal Malignant triton tumor in an infant: A case report and literature review. Transl Pediatr. (2020) 9:567–72. doi: 10.21037/tp.2020.03.12

PubMed Abstract | Crossref Full Text | Google Scholar

7. Khandelwal A, Gupta A, and Khandelwal K. Malignant peripheral nerve sheath tumor of kidney. Iran J Kidney Dis. (2011) 5:373.

PubMed Abstract | Google Scholar

8. Alharbi B. Malignant peripheral nerve sheath tumor of kidney-a case report. Int J Surg Case Rep. (2013) 4:914–6. doi: 10.1016/j.ijscr.2013.07.013

PubMed Abstract | Crossref Full Text | Google Scholar

9. Ouellet S, Doueik A, and Sabbagh R. Malignant peripheral nerve sheath tumour of the renal parenchyma presenting as a fast growing atypical renal cyst. Can Urol Assoc J. (2013) 7:E601–4. doi: 10.5489/cuaj.411

PubMed Abstract | Crossref Full Text | Google Scholar

10. Okumi M, Tanaka M, Noma M, Ichimaru N, Kobayashi Y, and Itoh K. A case of malignant peripheral nerve sheath tumor of the kidney. Hinyokika Kiyo. (2004) 50:421–4.

Google Scholar

11. Jankulovski N, Stankov O, Banev S, Petrovski D, Mickovski A, Mitevski A, et al. Isolated Malignant peripheral nerve sheath tumor of kidney capsule. Prilozi. (2008) 29:361–69.

PubMed Abstract | Google Scholar

12. Voznesensky MA, Yamase H, and Taylor JA 3rd. Malignant peripheral nerve sheath tumor of the renal pelvis. Urol Int. (2009) 83:370–2. doi: 10.1159/000241687

PubMed Abstract | Crossref Full Text | Google Scholar

13. Bins RB, Pinzon CE, da Silva Pereira LD, Bertuol M, Isolan P, and Takamatu EE. Malignant triton tumor of the kidney in a child: A case report. Int J Surg Case Rep. (2021) 85:106252. doi: 10.1016/j.ijscr.2021.106252

PubMed Abstract | Crossref Full Text | Google Scholar

14. Feng H, Tu N, and Bu L. Malignant peripheral nerve sheath tumor arising from transplanted kidney assessed by 18f-fdg pet/ct. Clin Nucl Med. (2020) 45:905–7. doi: 10.1097/RLU.0000000000003273

PubMed Abstract | Crossref Full Text | Google Scholar

15. Gallego A, Pontones JL, Ramos D, and Boronat F. Malignant triton tumor of the kidney. New location not previously reported. Urol Int. (2017) 99:121–3. doi: 10.1159/000434639

PubMed Abstract | Crossref Full Text | Google Scholar

16. Koppisetty S, Alessio RC, and Rajpurkar A. Breast metastases from a Malignant peripheral nerve sheath tumor of the kidney: an unusual presentation. Urol Ann. (2016) 8:387–90. doi: 10.4103/0974-7796.184878

PubMed Abstract | Crossref Full Text | Google Scholar

17. Williams SB, Szlyk GR, and Manyak MJ. Malignant peripheral nerve sheath tumor of the kidney. Int J Urol. (2006) 13:74–5. doi: 10.1111/j.1442-2042.2006.01238.x

PubMed Abstract | Crossref Full Text | Google Scholar

18. Sugawara M, Kobayashi E, Asano N, Yoshida A, and Kawai A. Malignant peripheral nerve sheath tumor of the femur: A rare diagnosis supported by complete immunohistochemical loss of H3k27me3. Int J Surg Pathol. (2017) 25:629–34. doi: 10.1177/1066896917709580

PubMed Abstract | Crossref Full Text | Google Scholar

19. Makise N, Sekimizu M, Kubo T, Wakai S, Hiraoka N, Komiyama M, et al. Clarifying the distinction between Malignant peripheral nerve sheath tumor and dedifferentiated liposarcoma: A critical reappraisal of the diagnostic utility of mdm2 and H3k27me3 status. Am J Surg Pathol. (2018) 42:656–64. doi: 10.1097/PAS.0000000000001014

PubMed Abstract | Crossref Full Text | Google Scholar

20. Blay JY, von Mehren M, Jones RL, Martin-Broto J, Stacchiotti S, Bauer S, et al. Synovial sarcoma: characteristics, challenges, and evolving therapeutic strategies. ESMO Open. (2023) 8:101618. doi: 10.1016/j.esmoop.2023.101618

PubMed Abstract | Crossref Full Text | Google Scholar

21. Goyal S, Mishra K, Sarkar U, Sharma S, and Kumari A. Diagnostic utility of wilms’ Tumour-1 protein (Wt-1) immunostaining in paediatric renal tumours. Indian J Med Res. (2016) 143:S59–67. doi: 10.4103/0971-5916.191776

PubMed Abstract | Crossref Full Text | Google Scholar

22. Pareja F, Brandes AH, Basili T, Selenica P, Geyer FC, Fan D, et al. Loss-of-function mutations in atp6ap1 and atp6ap2 in granular cell tumors. Nat Commun. (2018) 9:3533. doi: 10.1038/s41467-018-05886-y

PubMed Abstract | Crossref Full Text | Google Scholar

23. Lipinski P, Rokicki D, Bogdanska A, Lesiak J, Lefeber DJ, and Tylki-Szymanska A. Atp6ap1-cdg: follow-up and female phenotype. JIMD Rep. (2020) 53:80–2. doi: 10.1002/jmd2.12104

PubMed Abstract | Crossref Full Text | Google Scholar

24. Somatilaka BN, Sadek A, McKay RM, and Le LQ. Malignant peripheral nerve sheath tumor: models, biology, and translation. Oncogene. (2022) 41:2405–21. doi: 10.1038/s41388-022-02290-1

PubMed Abstract | Crossref Full Text | Google Scholar

25. Weiser G. Granular cell tumor and the phagocytozing form of schwann cells. Electron microscopic examinations of 3 cases (Author’s transl). Virchows Arch A Pathol Anat Histol. (1978) 380:49–57. doi: 10.1007/BF00432892

PubMed Abstract | Crossref Full Text | Google Scholar

26. Miki Y and Thway K. Malignant peripheral nerve sheath tumor with divergent glandular differentiation. Int J Surg Pathol. (2017) 25:310–3. doi: 10.1177/1066896917696749

PubMed Abstract | Crossref Full Text | Google Scholar

27. Van Haverbeke C, Ferdinande L, Verbeke S, Van Dorpe J, and Creytens D. Malignant peripheral nerve sheath tumour with heterologous liposarcomatous differentiation: case report and review of the literature. Pathology. (2018) 50:475–8. doi: 10.1016/j.pathol.2017.12.343

PubMed Abstract | Crossref Full Text | Google Scholar

28. Thway K, Hamarneh W, Miah AB, and Fisher C. Malignant peripheral nerve sheath tumor with rhabdomyosarcomatous and glandular elements: rare epithelial differentiation in a triton tumor. Int J Surg Pathol. (2015) 23:377–83. doi: 10.1177/1066896915583996

PubMed Abstract | Crossref Full Text | Google Scholar

29. Rekhi B, Ingle A, Kumar R, DeSouza MA, Dikshit R, and Jambhekar NA. Malignant peripheral nerve sheath tumors: clinicopathological profile of 63 cases diagnosed at a tertiary cancer referral center in Mumbai, India. Indian J Pathol Microbiol. (2010) 53:611–8. doi: 10.4103/0377-4929.71998

PubMed Abstract | Crossref Full Text | Google Scholar

30. Ortiz WJ, Salazar MS, Eager JJ, Sajid S, and Cervantes M. Primary intraosseous Malignant peripheral nerve sheath tumor of the humerus: report of a rare case. Cureus. (2022) 14:e33178. doi: 10.7759/cureus.33178

PubMed Abstract | Crossref Full Text | Google Scholar

Keywords: malignant peripheral nerve sheath tumor, kidney, granular cell, H3K27me3, case report

Citation: Ye D, Yan G, Cui W, Lai X, He W, Lei C and Wang W (2025) Case Report: Malignant peripheral nerve sheath tumor of the kidney with a novel granular cell morphology. Front. Oncol. 15:1559861. doi: 10.3389/fonc.2025.1559861

Received: 13 January 2025; Accepted: 06 October 2025;
Published: 16 October 2025.

Edited by:

Jiu Chen, Nanjing University, China

Reviewed by:

Sean R. Williamson, Cleveland Clinic, United States
Shalini Radhakrishnan, Kasturba Medical College, India

Copyright © 2025 Ye, Yan, Cui, Lai, He, Lei and Wang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Wei Wang, cmljZXdhbmc3OUAxMjYuY29t; Chengyong Lei, bmZ5eWxjeTIwMjRAMTYzLmNvbQ==

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.